Strides Arcolab gains on plan to invest $20 million in Biotech business

26 Sep 2014 Evaluate

Strides Arcolab is currently trading at Rs. 638.65, up by 3.10 points or 0.49% from its previous closing of Rs. 635.55 on the BSE.

The scrip opened at Rs. 642.40 and has touched a high and low of Rs. 658.00 and Rs. 625.10 respectively. So far 85064 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1050.00 on 05-Dec-2013 and a 52 week low of Rs. 343.80 on 26-Feb-2014.

Last one week high and low of the scrip stood at Rs. 739.15 and Rs. 628.70 respectively. The current market cap of the company is Rs. 3764.55 crore.

The promoters holding in the company stood at 27.67% while Institutions and Non-Institutions held 50.73% and 21.59% respectively.

Strides Arcolab intends to invest $20 million in Biotech business from the amount to be received from Mylan. The company has agreed to receive an amount of $150 million from Mylan Inc., USA as the full and final settlement against the Contingent Holdback of up to $250 million. After investments and providing for taxes the balance will be available for distribution to shareholders subject to the approval of board of directors.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

 

Strides Pharma Scien Share Price

902.00 -11.55 (-1.26%)
02-Jan-2026 10:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1726.70
Dr. Reddys Lab 1246.05
Cipla 1507.65
Zydus Lifesciences 915.70
Lupin 2117.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×